LEXINGTON, Mass.--(BUSINESS WIRE)--June 30, 2006--Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV - News) today announced that the underwriters have exercised an over-allotment option to purchase an additional 1,050,000 shares of its common stock in connection with its common stock offering that priced on June 28, 2006. Including the over-allotment shares being purchased, the offering will total 8,050,000 shares at a public offering price of $4.65 per share, resulting in expected net proceeds to the Company of approximately $34.8 million.
